凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06821 凯莱英

已收盘 06-12 16:08:21

92.750

+2.000

+2.20%

最高94.300	最低89.950	成交量22.67万
今开92.000	昨收90.750	日振幅4.79%
总市值334.83亿	流通市值25.56亿	总股本3.61亿
成交额2,104万	换手率0.82%	流通股本2,755万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":92.75,"timestamp":1781251701006,"preClose":90.75,"halted":0,"volume":226700,"delay":0,"changeRate":0.02203856749311295,"floatShares":27553260,"shares":361000000,"eps":3.16,"marketStatus":"已收盘","change":2,"latestTime":"06-12 16:08:21","open":92,"high":94.3,"low":89.95,"amount":21039690,"amplitude":0.047934,"askPrice":92.75,"askSize":300,"bidPrice":92.4,"bidSize":500,"shortable":3,"etf":0,"ttmEps":3.53274,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":5,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":90.75,"dividendRate":0.016151,"openAndCloseTimeList":[[1781227800000,1781236800000],[1781240400000,1781251200000]],"volumeRatio":0.354376,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":117.01,"timestamp":1781247600000,"preClose":113.61,"halted":0,"volume":6004800,"delay":0,"premium":"-31.58"}},"requestUrl":"/m/hq/s/06821/","defaultTab":"news","newsList":[{"id":"1162329012","title":"凯莱英回购94,000股A股，总金额约354.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162329012","media":"公告速递","labels":[],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162329012?lang=zh_cn&edition=full","pubTime":"2026-06-12 19:51","pubTimestamp":1781265107,"startTime":"0","endTime":"0","summary":"凯莱英医药集团（天津）股份有限公司于2026年6月12日在深圳证券交易所实施两次股份回购，共回购A股94,000股。公告显示，其中分别回购87,000股和7,000股，分别占该次回购公告前公司已发行股本的0.0262%及0.021%，每股回购价分别为人民币36.42元及人民币53.24元，合计支付约人民币354.12万元。回购完成后，公司A股股本变动如下：截至2026年6月12日，已发行股份为331,795,160股，库藏股为1,151,300股，总计332,946,460股。本次公告由公司联席公司秘书徐向科签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"凯莱英回购94,000股A股，总金额约354.12万元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642226709","title":"凯莱英(06821)：完成购回及注销根据2025年A股计划授出的部分限制性A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2642226709","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642226709?lang=zh_cn&edition=full","pubTime":"2026-06-12 19:25","pubTimestamp":1781263518,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，有关(其中包括)购回及注销根据2025年A股计划授出的部分限制性A股股份。截至本公告日期，已完成购回及注销(i)11名已离职激励对象所持有的根据2025年A股计划首次授予的及(ii)2名已离职激励对象所持有的根据2025年A股计划预留授予的合计共9.4万股限制性A股股份。公司已发行股本已由360,874,970股股份(包括333,040,460股A股及27,834,510股H股)减少至360,780,970股股份(包括332,946,460股A股及27,834,510股H股)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002821","BK0132","LU1328615791.USD","BK1191","06821","399300","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128285044","title":"凯莱英宣派末期股息每10股14.95港元，7月24日派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1128285044","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128285044?lang=zh_cn&edition=full","pubTime":"2026-06-10 22:01","pubTimestamp":1781100076,"startTime":"0","endTime":"0","summary":"凯莱英发布公告，更新截至2025年12月31日止年度末期股息的派息金额及预设派发货币。股东已于2026年6月10日批准宣派末期股息每10股13元人民币。根据最新公告，公司预设以港元派发，折算后每10股派息14.953705港元，换算汇率为1人民币兑1.150285港元。此次股息除净日为2026年6月25日，递交股份过户文件以符合获取股息分派的最后时限为6月26日16时30分，股份过户登记暂停期为6月29日至7月7日，权益登记日为7月7日，股息将于7月24日正式派发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"凯莱英宣派末期股息每10股14.95港元，7月24日派发","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642421265","title":"凯莱英(06821)将于7月24日派发末期股息每10股13元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642421265","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642421265?lang=zh_cn&edition=full","pubTime":"2026-06-10 21:58","pubTimestamp":1781099912,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，该公司将于2026年7月24日派发末期股息每10股13元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK0239","BK4585","06821","BK1191","LU1328615791.USD","BK0132","002821","VIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162101268","title":"凯莱英宣派末期股息每股1.30元，7月24日派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1162101268","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162101268?lang=zh_cn&edition=full","pubTime":"2026-06-10 21:45","pubTimestamp":1781099148,"startTime":"0","endTime":"0","summary":"凯莱英(06821)公布，在今日举行的2025年度股东周年大会上，股东审议通过了2025年度利润分配方案，将向全体股东派发末期股息。\n根据方案，每10股股份派发现金股利人民币13.00元（含税）。其中，A股股息以人民币支付，每股派息人民币1.30元；H股股息以港元支付，按中国人民银行2026年6月10日公布的人民币兑港元汇率中间价（人民币1元=1.150285港元）折算，每10股H股派息14.953705港元（含税），约合每股1.50港元。预期股息将于2026年7月24日（星期五）派发予全体股东。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"凯莱英宣派末期股息每股1.30元，7月24日派发","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642541972","title":"CRO概念盘初拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2642541972","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642541972?lang=zh_cn&edition=full","pubTime":"2026-06-10 09:36","pubTimestamp":1781055415,"startTime":"0","endTime":"0","summary":"CRO概念盘初拉升","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606103766089739.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606103766089739.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06821","BK1191","BK1576","03347","BK1141","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641105779","title":"医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641105779","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641105779?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:43","pubTimestamp":1780897412,"startTime":"0","endTime":"0","summary":"中邮证券表示，2026年第一季度，海外CXO行业整体呈现分化复苏格局，全球生物制药融资环境出现实质性改善，带动需求逐步回暖，但早期初创企业资金压力仍未完全缓解，不同细分赛道、不同规模企业的表现存在差异，行业结构性分化特征进一步凸显。展望2026年，海外头部CXO企业收入指引仍维持稳健小幅增长格局，叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏，行业景气度延续上行态势，成长确定性进一步增强。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983281","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995583.HKD","BK1521","BK1589","LU0516422366.SGD","BK1141","LU0051755006.USD","03759","LU0516422440.USD","HK0000306685.HKD","LU0516423091.SGD","HK0000320264.USD","LU0417516902.SGD","01548","LU0572944931.SGD","01521","LU0039217434.USD","LU2039709279.SGD","09939","06821","LU0326950275.SGD","LU1720050803.USD","BK1191","159938","LU0140636845.USD","02359","LU2242644610.SGD","LU3063872942.SGD","LU0417516738.SGD","LU0320764599.SGD","LU0348735423.USD","LU1688375341.USD","LU1880383366.USD","01873","LU0359201612.USD","02269","LU0307460666.USD","LU0856984785.SGD","LU0456827905.SGD","LU0516422952.EUR","LU2045819591.USD","LU1046422090.SGD","HK0000320223.HKD","SG9999002463.SGD","LU0348766576.USD","LU0348767384.USD","BK1574","LU0588546209.SGD","03347","BK1515","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178215137","title":"凯莱英5月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1178215137","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178215137?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:36","pubTimestamp":1780389401,"startTime":"0","endTime":"0","summary":"凯莱英医药集团（天津）股份有限公司于2026年6月2日披露截至2026年5月31日的股份变动月报表。报告显示，公司H股和A股的已发行数量均无变动，股本结构保持稳定。公告显示，公司H股（普通股）本月底数量为27,834,510股，较上月底无增减变动。根据披露，凯莱英进一步确认符合香港联交所《上市规则》有关公众持股比例的要求，整体股本持续维持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640966109","title":"股市必读：凯莱英（002821）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640966109","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640966109?lang=zh_cn&edition=full","pubTime":"2026-06-02 01:43","pubTimestamp":1780335787,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，凯莱英报收于115.39元，下跌1.73%，换手率2.47%，成交量7.82万手，成交额9.32亿元。董秘最新回复投资者： 你好，公司最新股东户数是多少，或者截止5.20收盘后的股东户数是多少？公司在信息披露方面为遵循谨慎公平原则，故不在互动平台上披露股东人数信息。当日关注点来自交易信息汇总：6月1日主力资金净流入834.43万元，显示主力对个股短期态度偏积极。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","002821","BK1191","BK0132","06821","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638769349","title":"富国基金管理有限公司增持凯莱英(06821)5.33万股 每股作价约98.28港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638769349","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638769349?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:24","pubTimestamp":1779971092,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月22日，富国基金管理有限公司增持凯莱英(06821)5.33万股，每股作价98.2793港元，总金额约为523.83万港元。增持后最新持股数目约为141.13万股，最新持股比例为5.07%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447375.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","BK0239","BK1191","LU1328615791.USD","002821","06821","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638507992","title":"4家CRO，减员5797人","url":"https://stock-news.laohu8.com/highlight/detail?id=2638507992","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638507992?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:38","pubTimestamp":1779881880,"startTime":"0","endTime":"0","summary":"十家头部CRO企业员工总数从97918人增至98299人，增幅0.39%。表面看人数基本稳定，但内部差异化显著，药明康德、九洲药业、昭衍新药、毕得医药合计减少5797人；康龙化成、泰格医药、凯莱英仍在加人。01CRO扩员红利见顶2025年，国内头部CRO企业的人力扩张基本停了下来。两家公司一减一增，说明CRO人员扩张只会流向更明确的业务方向。此外，康龙化成在2026年一季度收入35.78亿元，同比增长15.48%；归母净利润3.35亿元，同比增长9.75%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-27/doc-inhzivfk8415193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06821","BK1191","BK1576","03347","06127","BK1141","03759","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638750297","title":"小摩减持凯莱英(06821)6.77万股 每股作价约98.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638750297","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638750297?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:25","pubTimestamp":1779881124,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月21日，小摩减持凯莱英(06821)6.77万股，每股作价98.5021港元，总金额约为666.86万港元。减持后最新持股数目约为163.88万股，最新持股比例为5.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","IE00BFXG1179.USD","LU1032466523.USD","IE000M9KFDE8.USD","LU1267930490.SGD","LU2237443622.USD","LU1145028129.USD","LU2237443978.SGD","EWH","LU0048584097.USD","LU1670628061.USD","IE00BJTD4N35.SGD","LU0070302665.USD","LU0211326839.USD","LU1496350171.SGD","LU2211815571.USD","LU0689472784.USD","IE00BLSP4239.USD","LU0211328371.USD","LU1162221912.USD","IE00BBT3K403.USD","LU0203347892.USD","LU0820561818.USD","LU1629891620.HKD","IE00BJTD4V19.USD","LU2746668974.SGD","LU0238689110.USD","SG9999002232.USD","JPO","LU0943347566.SGD","LU2756315318.SGD","LU0203345920.USD","LU0417517546.SGD","BK4550","LU1720051017.SGD","BK4207","LU1914381329.SGD","LU2237443895.HKD","LU1496350502.SGD","06821","LU2552382215.SGD","IE00BHPRN162.USD","LU2552382058.USD","JPX","002821","LU1119994496.HKD","BK0239","LU0211326755.USD","IE00BYXW3230.USD","JPMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637584807","title":"港股异动 | 凯莱英(06821)涨超7% 新兴业务表现强劲 机构看好其长期高增长确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2637584807","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637584807?lang=zh_cn&edition=full","pubTime":"2026-05-21 14:51","pubTimestamp":1779346283,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英涨超7%，截至发稿，涨7.85%，报99.65港元，成交额7212万港元。消息面上， 凯莱英一季度业绩显示，营业收入18.02亿元，同比增16.91%；经调整归母净利润4.23亿元，同比增27.91%。分业务来看，一季度小分子CDMO 业务收入12亿元，同比增长 0.43%，恒定汇率下增长 3.26%；新兴业务收入5.98亿元，同比增长74.07%，主要是化学大分子和生物大分子业务板块增长强劲。公司在高景气度赛道的后期订单规模扩大和前瞻性投入，可望带来较强的长期高增长确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444417.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK0239","06821","002821","LU1328615791.USD","VXUS","BK4585","BK0132","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635203891","title":"凯莱英（002821）披露召开2025年度股东会及系列类别股东会通知，5月15日股价下跌3.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635203891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635203891?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:04","pubTimestamp":1778853891,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，凯莱英报收于117.97元，较前一交易日下跌3.45%，最新总市值为425.72亿元。该股当日开盘122.41元，最高125.31元，最低116.92元，成交额达10.31亿元，换手率为2.7%。近日，凯莱英医药集团（天津）股份有限公司发布《关于召开2025年度股东会、2026年第二次A股类别股东会及2026年第二次H股类别股东会的通知》。股权登记日为2026年6月2日，A股股东可通过深圳证券交易所系统或互联网投票系统参与网络投票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500043789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","LU1328615791.USD","BK0132","BK0239","002821","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181849212","title":"凯莱英更新末期股息派息安排，每10股派13元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1181849212","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181849212?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:21","pubTimestamp":1778847710,"startTime":"0","endTime":"0","summary":"凯莱英医药集团发布关于截至2025年12月31日止年度末期股息的更新公告，就香港过户登记处信息及代扣所得税安排作出补充。公司已宣派普通末期股息，基准为每10股派发现金红利13元人民币。由于预设派发货币为港元，最终每股港元派息金额及汇率有待公布。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"凯莱英更新末期股息派息安排，每10股派13元人民币","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635084117","title":"凯莱英(06821)将于7月24日派发末期股息每10股13元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635084117","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635084117?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:20","pubTimestamp":1778847630,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，该公司将于2026年7月24日派发截至2025年12月31日止年度的末期股息每10股13元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","VIG","BK0239","002821","BK1191","BK4588","LU1328615791.USD","BK4585","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193309403","title":"凯莱英拟于股东周年大会审议2025年度利润分配方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1193309403","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193309403?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:01","pubTimestamp":1778846485,"startTime":"0","endTime":"0","summary":"凯莱英发布2025年股东周年大会通告，将于2026年6月10日举行股东周年大会，审议包括2025年度利润分配方案在内的多项议案。该方案仍为董事会建议，须经股东大会批准后方可实施。股东如有意出席大会，H股股东须于2026年6月4日下午四时三十分前完成股份过户登记。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"凯莱英拟于股东周年大会审议2025年度利润分配方案","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178542171","title":"花旗集团于凯莱英H股持股比例自5.91%降至5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178542171","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178542171?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:07","pubTimestamp":1778666870,"startTime":"0","endTime":"0","summary":"根据香港交易所披露的最新权益变动信息，花旗集团在凯莱英H股的持股比例出现下降。具体数据显示，截至5月7日，花旗集团所持好仓头寸占该股已发行H股的比例已从此前的5.91%降至5.36%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821","BK1191","BK0239","002821","BK0132","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634740914","title":"5月11日凯莱英涨5.26%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634740914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634740914?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:36","pubTimestamp":1778488569,"startTime":"0","endTime":"0","summary":"证券之星消息，5月11日凯莱英涨5.26%，收盘报130.08元，换手率3.46%，成交量10.96万手，成交额13.92亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共67家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.742，较上一交易日下跌2.72%，近一年上涨10.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100022129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","06821","002821","BK0132","159760","BK1191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634409976","title":"凯莱英涨5.26%，开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2634409976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634409976?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:35","pubTimestamp":1778488559,"startTime":"0","endTime":"0","summary":"今日凯莱英涨5.26%，收盘报130.08元。2026年4月1日，开源证券研究员余汝意发布了对凯莱英的研报《公司信息更新报告：收入利润高质增长，多赛道景气共振下迈向加速周期》，该研报对凯莱英给出“买入”评级。研报中预计2026-2028年公司归母净利润为15.07/18.59/23.12亿元，EPS为4.18/5.15/6.41元，当前股价对应PE为24.1/19.5/15.7倍，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中国银河的宋丽莹、程培。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100022123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","161027","06821"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.1172},{"period":"3month","weight":0.1315},{"period":"6month","weight":0.1748},{"period":"1year","weight":0.1963},{"period":"ytd","weight":0.2746}],"compareEarnings":[{"period":"1week","weight":-0.0398},{"period":"1month","weight":-0.0797},{"period":"3month","weight":-0.0478},{"period":"6month","weight":-0.0665},{"period":"1year","weight":-0.0048},{"period":"ytd","weight":-0.0539}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团（天津）股份有限公司是一家主要从事提供医药外包一站式综合服务的中国公司。该公司的业务包括小分子药物定制研发生产（CDMO）、化学大分子CDMO、临床研究服务、制剂CDMO、生物大分子CDMO、技术输出和合成生物技术。该公司的产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.058446},{"month":2,"riseRate":0.4,"avgChangeRate":0.006896},{"month":3,"riseRate":0.4,"avgChangeRate":0.004398},{"month":4,"riseRate":0.6,"avgChangeRate":-0.036175},{"month":5,"riseRate":0.4,"avgChangeRate":0.006808},{"month":6,"riseRate":0.4,"avgChangeRate":0.011291},{"month":7,"riseRate":0.5,"avgChangeRate":0.064856},{"month":8,"riseRate":0.25,"avgChangeRate":-0.064097},{"month":9,"riseRate":0.75,"avgChangeRate":0.16322},{"month":10,"riseRate":0,"avgChangeRate":-0.125554},{"month":11,"riseRate":0.5,"avgChangeRate":0.010602},{"month":12,"riseRate":0.25,"avgChangeRate":-0.010177}],"exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}